Conventional echocardiography and cardiac biomarkers, such as N-terminal pro-B-type natriuretic peptide (NT-proBNP) and cardiac troponin I (cTnI), are the gold standard methods for diagnosing CHF [1]. This evidence concerns the gene TNNI3 and congestive heart failure.